Toronto, Ontario (July 3, 2020) – NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) (TSXV:KHV.P) (the “Corporation”) wishes to clarify certain information appearing in the news release (the “Closing News Release”), dated June 25, 2020, announcing the completion of a reverse takeover structured as a court approved plan of arrangement (the “Arrangement”) and a share consolidation (the “Consolidation”) on the terms and conditions set out in the arrangement agreement dated April 24, 2020 (the “Arrangement Agreement”) among the Corporation, 2752695 Ontario Inc. (a wholly-owned subsidiary of the Corporation) and 2576560 Ontario Inc. doing business as NeuPath Health (“2576560”) and in the Corporation’s filing statement dated May 29, 2020 (the “Filing Statement”).

Previously, the Corporation had disclosed that an aggregate of 24,281,488 common shares of the Corporation (post-Consolidation) were issued as consideration for 24,281,488 common shares of 2576560. The Corporation had also disclosed that upon the completion of the Arrangement and the Consolidation, 28,150,988 common shares of the Corporation will be issued and outstanding.

Click here to see the full PDF Press Release.